Cargando…

Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa

Rubella is generally a mild childhood disease, but infection during early pregnancy may cause spontaneous abortion or congenital rubella syndrome (CRS), which may entail a variety of birth defects. Since vaccination at levels short of those necessary to achieve eradication may increase the average a...

Descripción completa

Detalles Bibliográficos
Autores principales: Metcalf, C. J. E., Cohen, C., Lessler, J., McAnerney, J. M., Ntshoe, G. M., Puren, A., Klepac, P., Tatem, A., Grenfell, B. T., Bjørnstad, O. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565806/
https://www.ncbi.nlm.nih.gov/pubmed/23152104
http://dx.doi.org/10.1098/rsif.2012.0756
_version_ 1782258472793931776
author Metcalf, C. J. E.
Cohen, C.
Lessler, J.
McAnerney, J. M.
Ntshoe, G. M.
Puren, A.
Klepac, P.
Tatem, A.
Grenfell, B. T.
Bjørnstad, O. N.
author_facet Metcalf, C. J. E.
Cohen, C.
Lessler, J.
McAnerney, J. M.
Ntshoe, G. M.
Puren, A.
Klepac, P.
Tatem, A.
Grenfell, B. T.
Bjørnstad, O. N.
author_sort Metcalf, C. J. E.
collection PubMed
description Rubella is generally a mild childhood disease, but infection during early pregnancy may cause spontaneous abortion or congenital rubella syndrome (CRS), which may entail a variety of birth defects. Since vaccination at levels short of those necessary to achieve eradication may increase the average age of infection, and thus potentially the CRS burden, introduction of the vaccine has been limited to contexts where coverage is high. Recent work suggests that spatial heterogeneity in coverage should also be a focus of concern. Here, we use a detailed dataset from South Africa to explore the implications of heterogeneous vaccination for the burden of CRS, introducing realistic vaccination scenarios based on reported levels of measles vaccine coverage. Our results highlight the potential impact of country-wide reductions of incidence of rubella on the local CRS burdens in districts with small population sizes. However, simulations indicate that if rubella vaccination is introduced with coverage reflecting current estimates for measles coverage in South Africa, the burden of CRS is likely to be reduced overall over a 30 year time horizon by a factor of 3, despite the fact that this coverage is lower than the traditional 80 per cent rule of thumb for vaccine introduction, probably owing to a combination of relatively low birth and transmission rates. We conclude by discussing the likely impact of private-sector vaccination.
format Online
Article
Text
id pubmed-3565806
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Royal Society
record_format MEDLINE/PubMed
spelling pubmed-35658062013-02-13 Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa Metcalf, C. J. E. Cohen, C. Lessler, J. McAnerney, J. M. Ntshoe, G. M. Puren, A. Klepac, P. Tatem, A. Grenfell, B. T. Bjørnstad, O. N. J R Soc Interface Research Articles Rubella is generally a mild childhood disease, but infection during early pregnancy may cause spontaneous abortion or congenital rubella syndrome (CRS), which may entail a variety of birth defects. Since vaccination at levels short of those necessary to achieve eradication may increase the average age of infection, and thus potentially the CRS burden, introduction of the vaccine has been limited to contexts where coverage is high. Recent work suggests that spatial heterogeneity in coverage should also be a focus of concern. Here, we use a detailed dataset from South Africa to explore the implications of heterogeneous vaccination for the burden of CRS, introducing realistic vaccination scenarios based on reported levels of measles vaccine coverage. Our results highlight the potential impact of country-wide reductions of incidence of rubella on the local CRS burdens in districts with small population sizes. However, simulations indicate that if rubella vaccination is introduced with coverage reflecting current estimates for measles coverage in South Africa, the burden of CRS is likely to be reduced overall over a 30 year time horizon by a factor of 3, despite the fact that this coverage is lower than the traditional 80 per cent rule of thumb for vaccine introduction, probably owing to a combination of relatively low birth and transmission rates. We conclude by discussing the likely impact of private-sector vaccination. The Royal Society 2013-01-06 /pmc/articles/PMC3565806/ /pubmed/23152104 http://dx.doi.org/10.1098/rsif.2012.0756 Text en http://creativecommons.org/licenses/by/3.0/ © 2012 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original author and source are credited.
spellingShingle Research Articles
Metcalf, C. J. E.
Cohen, C.
Lessler, J.
McAnerney, J. M.
Ntshoe, G. M.
Puren, A.
Klepac, P.
Tatem, A.
Grenfell, B. T.
Bjørnstad, O. N.
Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa
title Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa
title_full Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa
title_fullStr Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa
title_full_unstemmed Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa
title_short Implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in South Africa
title_sort implications of spatially heterogeneous vaccination coverage for the risk of congenital rubella syndrome in south africa
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565806/
https://www.ncbi.nlm.nih.gov/pubmed/23152104
http://dx.doi.org/10.1098/rsif.2012.0756
work_keys_str_mv AT metcalfcje implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica
AT cohenc implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica
AT lesslerj implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica
AT mcanerneyjm implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica
AT ntshoegm implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica
AT purena implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica
AT klepacp implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica
AT tatema implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica
AT grenfellbt implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica
AT bjørnstadon implicationsofspatiallyheterogeneousvaccinationcoveragefortheriskofcongenitalrubellasyndromeinsouthafrica